Bioeasy’s business activities include:

1. Providing bioinformatics analysis for Next Generation Sequencing and Microarray technologies across all the platforms.
2. Providing bioinformatics plus wetlab service to produce high quality data.
3. Bioinformatics training and facility set up for customers new to NGS and microarray
4. Market Assisted Selection (MAS) biochip development.

BioEasy’s business model entails providing total solutions to its customers in terms of bioinformatics, data generation and analysis. The company’s customers engage not only its bioinformatics analysis service but also data generation from the wetlab due to its access to a local sequencing lab.